Home › Acute Myeloid Leukemia › Florida › Tampa
Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa Tampa, FL
29 pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Tampa (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Nagre-recruitPhase 2
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Nagre-recruitPhase 2/3
- Moffitt Cancer Center /ID# 279192, Tampa
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Nagre-recruitPhase 1
- Moffitt Cancer Center, Tampa
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Nagre-recruitPhase 3
- Moffit Cancer center, Tampa
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Nagre-recruitPhase 3
- Tampa General Hospital, Tampa
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
A Study of BGB-11417 in Participants With Myeloid Malignancies
Nagre-recruitPhase 1/2
- Tampa General Hospital, Tampa
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
Nagre-recruitPhase 1
- Moffitt Cancer Center, Tampa
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Nagre-recruitPhase 1/2
- Moffitt Cancer Center and Research Institute Hospital, Tampa
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Nagre-recruitPhase 1/2
- Moffitt Cancer Center, Tampa
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
Nagre-recruitPhase 1
- Moffitt Cancer Center, Tampa
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Nagre-recruitPhase 1/2
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Nagre-recruitPhase 3
- Saint Joseph's Hospital - Tampa, Tampa
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Nagre-recruitPhase 3
- Moffitt Cancer Center & Research Institute, Tampa
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Nagre-recruitPhase 1
- H Lee Moffitt Cancer Center & Research Institute, Tampa
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Nagre-recruitPhase 3
- Moffitt Cancer Center, Tampa
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Nagre-recruitPhase 2
- Moffitt Cancer Center, Tampa
BCL2i CLAG-M in R/R Acute Myeloid Leukemia
Nagre-recruitPhase 2
- Moffitt Cancer Center, Tampa
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Nagre-recruitPhase 1/2
- Moffitt Cancer Center, Tampa
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Nagre-recruitPhase 1
- Moffitt Cancer Center, Tampa
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Nagre-recruitPhase 2
- Moffitt Cancer Center, Tampa
Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
Nagre-recruitPhase 2
- Moffitt Cancer Center, Tampa
CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
Nagre-recruitPhase 1
- Moffitt Cancer Center, Tampa
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Nagre-recruitPhase 1
- Moffitt, Tampa
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Nagre-recruitPhase 1
- Moffitt Cancer Center, Tampa
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
Nagre-recruitPhase 1
- Moffitt Cancer Center, Tampa
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Nagre-recruitPhase 1
- Moffitt Cancer Center, Tampa
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Moffitt Cancer Center, Tampa
Study of REM-422 in Patients With AML or Higher Risk MDS
Nagre-recruitPhase 1
- Moffitt Cancer Center, Tampa
Pag-aaral para sa Acute Myeloid Leukemia sa ibang lungsod
- Houston, TX85 pag-aaral
- New York City, NY51 pag-aaral
- Boston, MA44 pag-aaral
- Seattle, WA41 pag-aaral
- Baldwin Park, CA40 pag-aaral
- Columbus, OH35 pag-aaral
- Philadelphia, PA34 pag-aaral
- Durham, NC33 pag-aaral
- Atlanta, GA31 pag-aaral
- Chicago, IL26 pag-aaral
- Portland, OR25 pag-aaral
- Washington, DC24 pag-aaral
Iba pang pag-aaral sa Tampa
- Non-Small Cell Lung Cancer51 pag-aaral
- Kanser sa Suso43 pag-aaral
- Kanser (lahat ng uri)39 pag-aaral
- Colorectal Cancer34 pag-aaral
- Metastatic Cancer29 pag-aaral
- Kanser sa Baga29 pag-aaral
- Kanser sa Pancreas26 pag-aaral
- Kanser sa Ovary21 pag-aaral
- Melanoma19 pag-aaral
- Myelodysplastic Syndromes19 pag-aaral
- Kanser sa Prostate18 pag-aaral
- Pagkabigo ng Puso18 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.